Cited by 422Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesNeuroscience and Neuropharmacology Research

The neurocircuitry of addiction: an overview

Open access
Feltenstein, M W, See, R E·2008·British Journal of Pharmacology

Abstract

Drug addiction presents as a chronic relapsing disorder characterized by persistent drug-seeking and drug-taking behaviours. Given the significant detrimental effects of this disease both socially and economically, a considerable amount of research has been dedicated to understanding a number of issues in addiction, including behavioural and neuropharmacological factors that contribute to the development, loss of control and persistence of compulsive addictive behaviours. In this review, we will give a broad overview of various theories of addiction, animal models of addiction and relapse, drugs of abuse, and the neurobiology of drug dependence and relapse. Although drugs of abuse possess diverse neuropharmacological profiles, activation of the mesocorticolimbic system, particularly the ventral tegmental area, nucleus accumbens, amygdala and prefrontal cortex via dopaminergic and glutamatergic pathways, constitutes a common pathway by which various drugs of abuse mediate their acute reinforcing effects. However, long-term neuroadaptations in this circuitry likely underlie the transition to drug dependence and cycles of relapse. As further elucidated in more comprehensive reviews of various subtopics on addiction in later sections of this special issue, it is anticipated that continued basic neuroscience research will aid in the development of effective therapeutic interventions for the long-term treatment of drug-dependent individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjp.2008.51

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 265 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Koob GF, Le Moal M (2006). Nicotine. In: Koob GF, Le Moal M (eds). Neurobiology of Addiction. Academic Press: London. pp 243-287.
  2. Kornetsky C, Bain G (1990). Brain-stimulation reward: a model for drug induced euphoria. In: Adler MW, Cowan A (eds). Testing and Evaluation of Drug of Abuse. Wiley-Liss: New York. pp 211-231.
  3. Kuczenski R, Segal DS (1994). Neurochemistry of amphetamine. In: Cho AK (ed). Amphetamine and its Analogs. Academic Press: San Diego. pp 81-113.

Cited by

Sorted by citations

Authors
Feltenstein, M. W., & See, R. E.
Affiliations
Medical University of South Carolina (US)
Corresponding author
Feltenstein, M W
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-05
Volume
154
Issue
2
Pages
261-274
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1867555087
Cited by
421
References
265
Citations by year
2026: 8 · 2025: 14 · 2024: 12 · 2023: 13 · 2022: 14 · 2021: 18 · 2020: 16 · 2019: 21 · 2018: 19 · 2017: 18 · 2016: 28 · 2015: 22 · 2014: 28 · 2013: 41 · 2012: 40
FWCI
3.02
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1c06rr015455-01a1, DA016511, DA015369)
  • National Institute on Drug Abuse (DA016511, DA07288, R01DA010462, DA 015369, P50DA015369, P50DA016511, DA010462, T32DA007288)
  • National Center for Research Resources (C06 RR-015455)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
drug addiction, neurocircuitry, relapse, mesocorticolimbic system, ventral tegmental area, nucleus accumbens, amygdala, prefrontal cortex, dopaminergic pathways, glutamatergic pathways, neural adaptation, animal models of addiction, drugs of abuse, addiction theory, compulsive drug seeking
MeSH terms
Animals, Behavior, Animal, Central Nervous System Agents, Dopamine, Humans, Limbic System, Models, Psychological, Neural Pathways, Recurrence, Substance Withdrawal Syndrome, Behavior, Addictive, Neurotransmitter Agents, Glutamic Acid, Substance-Related Disorders, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review